Summary
Speciality pharmacy is definitionally more expensive and complicated than retail pharmacy, so it seems logical that situating those speciality pharmacy services in an oncologist’s or rheumatologist’s office would be beneficial for patients, their families, and payers who all have an interest in making sure the therapy regimen is completed as prescribed.
But nothing in the world of pharmacy in the US is ever simple with conflicting interests from payers and manufacturers along side the logistical and operational challenges of speciality medicines. Co-founder and CEO Ogi Kavazovic joined us for a discussion on the difference a speciality pharmacy in a clinic can make and how his company House Rx is helping clinics navigate the tricky dynamics between drug manufacturers and PBMs.
Check out the conversation below!
Connect & learn more
What we covered:
00:00 Introductions
00:14 Ogi's journey to healthcare
03:51 What is specialty pharmacy?
05:52 What does the specialty pharmacy patient journey look like today?
11:41 Bringing it in house
24:24 The business impact for clinics
26:55 What House Rx looks like from a clinic perspective
